(4S)-4-Hydroxy-L-isoleucine
CAS: 55399-93-4
Rif. 3D-FH46718
5mg | Fuori produzione | ||
10mg | Fuori produzione | ||
25mg | Fuori produzione |
Informazioni sul prodotto
- (2S,4S)-2-Amino-4-hydroxy-3-methylpentanoic acid
- (2S,3R)-2-Amino-4-hydroxy-3-methylpentanoic acid
- (2S,3R,4S)-4-Hydroxyisoleucine
- (4S)-4-Hydroxy-<span class="text-smallcaps">L</span>-isoleucine
- 2-Amino-2,3,5-trideoxy-3-methyl-<span class="text-smallcaps">L</span>-ribonic acid
- 2-Amino-4-Hydroxy-3-Methylpentanoic Acid (Non-Preferred Name)
- 4-Hydroxy-L-isoleucine
- <span class="text-smallcaps">L</span>-Ribonic acid, 2-amino-2,3,5-trideoxy-3-methyl-
- L-4-Hydroxyisoleucine
- L-erythro-Pentonic acid, 2-amino-2,3,5-trideoxy-3-methyl-, (4ξ)-
- Vedi altri sinonimi
- 2-Amino-2,3,5-trideoxy-3-methyl-L-ribonic acid
- L-Ribonic acid, 2-amino-2,3,5-trideoxy-3-methyl-
(4S)-4-Hydroxy-L-isoleucine is a novel synthetic anti-inflammatory agent that has been shown to be effective in the treatment of inflammatory bowel disease. This drug is derived from L-isoleucine and has been shown to inhibit proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin 6 (IL6). The structure of this drug was determined by X-ray crystallography. The synthesis of this compound starts with the condensation reaction between 3,5-dichloroacrylic acid and hydroxyacetone. The product is then purified by means of column chromatography, yielding 4S-(3,5-dichloroacrylic acid)-4-(hydroxyacetone)l--L-isoleucine.